Norepinephrine/dopamine transporter + GABA-A receptor

Class

NET/DAT inhibitor + GABA-A PAM

This mechanism combines two distinct actions in a single molecule: inhibition of the norepinephrine transporter (NET) and dopamine transporter (DAT), and positive allosteric modulation of the GABA-A receptor. NET and DAT normally clear the neurotransmitters norepinephrine and dopamine from the synapse after release; blocking them prolongs and intensifies signaling through these catecholamine pathways, which is associated with heightened arousal, attention, and mood elevation. GABA-A receptors are ligand-gated chloride channels that mediate the brain's principal inhibitory neurotransmission; a positive allosteric modulator (PAM) does not activate the receptor directly but enhances its response to GABA, producing calming, anxiolytic, and sedative effects. Pairing a stimulating monoaminergic mechanism with a calming GABAergic one allows a single agent to address conditions where both excitatory drive and inhibitory tone need adjustment, such as attention disorders complicated by anxiety or agitation, or dependence syndromes where blunting the reinforcing surge of dopamine while providing sedative support may reduce compulsive use. This dual profile broadly matters across psychiatry and neurology, wherever monoamine dysregulation and impaired inhibitory signaling coexist.